Telemus Capital’s Medtronic MDT Stock Holding History

Telemus Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$1.22M	Sell	14,807 -3,446	-19%	-$263K	0.1%	143
2023 Q3	$1.43M	Sell	18,253 -2,801	-13%	-$234K	0.13%	128
2023 Q2	$1.85M	Buy	21,054 +904	+4%	+$77.8K	0.16%	119
2023 Q1	$1.62M	Buy	20,150 +1,286	+7%	+$105K	0.14%	135
2022 Q4	$1.53M	Sell	18,864 -460	-2%	-$37.3K	0.14%	138
2022 Q3	$1.56M	Buy	19,324 +1,590	+9%	+$143K	0.16%	122
2022 Q2	$1.59M	Sell	17,734 -7,264	-29%	-$736K	0.15%	124
2022 Q1	$2.77M	Buy	24,998 +8,471	+51%	+$895K	0.24%	98
2021 Q4	$1.71M	Sell	16,527 -518	-3%	-$60K	0.14%	136
2021 Q3	$2.14M	Buy	17,045 +1,365	+9%	+$177K	0.18%	109
2021 Q2	$1.95M	Sell	15,680 -1,919	-11%	-$241K	0.14%	123
2021 Q1	$2.12M	Sell	17,599 -1,588	-8%	-$186K	0.15%	125
2020 Q4	$2.25M	Buy	19,187 +564	+3%	+$62.1K	0.17%	106
2020 Q3	$2.05M	Sell	18,623 -918	-5%	-$92.2K	0.15%	122
2020 Q2	$1.77M	Buy	19,541 +2,102	+12%	+$202K	0.14%	123
2020 Q1	$1.72M	Buy	17,439 +5,911	+51%	+$629K	0.14%	126
2019 Q4	$1.31M	Buy	11,528 +542	+5%	+$59.5K	0.1%	154
2019 Q3	$1.19M	Sell	10,986 -199	-2%	-$20.8K	0.1%	158
2019 Q2	$1.11M	Buy	11,185 +260	+2%	+$23.7K	0.1%	152
2019 Q1	$995K	Sell	10,925 -707	-6%	-$63.3K	0.08%	191
2018 Q4	$1.06M	Buy	11,632 +42	+0.4%	+$3.92K	0.09%	174
2018 Q3	$1.14M	Buy	11,590 +544	+5%	+$50.3K	0.09%	182
2018 Q2	$946K	Buy	11,046 +261	+2%	+$21.8K	0.07%	212
2018 Q1	$866K	Buy	10,785 +1,792	+20%	+$148K	0.07%	217
2017 Q4	$726K	Buy	+8,993	New	+$720K	0.06%	233
2017 Q3	–	Sell	-2,519	Closed	-$224K	–	343
2017 Q2	$224K	Buy	+2,519	New	+$212K	0.02%	327
2016 Q4	–	Sell	-2,502	Closed	-$216K	–	328
2016 Q3	$216K	Buy	2,502 +35	+1%	+$3.05K	0.02%	322
2016 Q2	$214K	Buy	+2,467	New	+$200K	0.03%	316

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Telemus Capital's MDT Position: Q4 2023 in Review

Telemus Capital reduced its Medtronic (MDT) stake by 19% in Q4 2023, selling an estimated $263K and leaving 14,807 shares worth $1.22M. The position accounts for 0.1% of the portfolio, ranked #143.

Telemus Capital first reported a position in MDT in Q2 2016 and has held it in 28 quarters since. The position peaked at $2.77M in Q1 2022. 2,078 funds tracked by Wall St. Rank hold MDT as of Q4 2023.

Telemus Capital held 14,807 shares of Medtronic worth $1.22M as of Q4 2023.
Telemus Capital sold 3,446 Medtronic shares in Q4 2023, an estimated $263K.
Medtronic made up 0.1% of Telemus Capital's portfolio in Q4 2023, its #143 holding.
Telemus Capital first reported a position in Medtronic in Q2 2016 and has held it in 28 quarters since.
Telemus Capital's Medtronic position peaked at $2.77M in Q1 2022.
2,078 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.

Based on Telemus Capital's 13F filing for Q4 2023, filed 1 Feb 2024.